Momenta Pharmaceuticals to Webcast Presentation at Two Upcoming Investor Conferences

CAMBRIDGE, Mass., Feb. 24, 2016 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that it will webcast its presentation at two upcoming investor conferences.

Cowen & Company 36th Annual Health Care ConferenceMonday, March 7, 2016 at 4:00 p.m. ET in Boston, MA

Barclays Global Healthcare ConferenceTuesday, March 15, 2016 at 4:50 p.m. ET in Miami, FL

The audio webcast of the presentation will be available live on the “Investors” section of the company’s website located at www.momentapharma.com.  A replay of the presentation will be posted on the Momenta website approximately one hour after the event and will be available for two weeks following the presentation.

About MomentaMomenta Pharmaceuticals is a biotechnology company specializing in the detailed structural analysis of complex drugs and is headquartered in Cambridge, MA. Momenta is applying its technology to the development of generic versions of complex drugs, biosimilar and potentially interchangeable biologics, and to the discovery and development of novel therapeutics for oncology and autoimmune indications.

To receive additional information about Momenta, please visit the website at www.momentapharma.com, which does not form a part of this press release.

Our logo, trademarks, and service marks are the property of Momenta Pharmaceuticals, Inc. All other trade names, trademarks, or service marks are property of their respective owners.

Contact:
Sarah Carmody
Momenta Pharmaceuticals
1-617-395-5189
[email protected]

Source: Momenta Pharmaceuticals, Inc.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• XRP News: 24% Surge Proves the Rally Is Real, and Smart Wallets Already Know What Comes Next
• Frontieras North America Inc. Positions Domestic Coal as America’s Answer to Energy Supply Disruption
• Klear.ai Welcomes Veteran P&C Claims Executive Jonathan Gerdes to the Klear.ai Team